Search

How to apply for an EHA Research Grant

On this page, we explain all of the actions you'll need to take when submitting a grant application. You can also get a basic overview of the process in our EHA Research Grants diagram.

Read more

How to apply for an EHA Bilateral Collaborative Grant

On this page, we explain all of the actions you'll need to take when submitting an EHA Bilateral Collaborative Grant application.

Read more

How to apply for an EHA Kick-off Grant

On this page, we explain all of the actions you'll need to take when submitting an EHA Kick-off Grant application.

Read more

EHA Research Grants

The call for applications will close on October 15, 2024, at 15:00 (CEST).

Read more

EHA Bilateral Collaborative Grant

The call for applications will close on October 15, 2024, at 15:00 (CEST).

Read more

Support for Research

Research in hematology is critical to improving our understanding of diseases, clinical practice, and overall patient care. Support for research in hematology is a priority for EHA, including for our European Affairs team.

Read more

Selected EMA news

Most of EHA’s regulatory activities focus on collaboration with the European Medicines Agency (EMA).

Read more

Registration

Register here

Individual registrationHybrid registration includes:

In-person access to the scientific and educational sessions of the meeting
Access to the virtual platform
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8, 2025
Access to the Welcome Reception
Access to the Poster Session(s) and…

Read more

Highlights from the SWG

SWG Session at EHA2023ELN-EHA SWG for CML: CML: modelling the futureChairJane Apperley (United Kingdom)

Topics and presenters
Identifying new targets for BCR::ABL1 inhibition: Oliver Hantschel (Germany). Dissecting phylogenetic trees in CML: Aleksandra Kamizela (United Kingdom).

Read more

Immune Therapies for Hematologic Disorders

Recently the treatment of hematological and solid malignancies has been revolutionized by the introduction of novel immunotherapeutic strategies.

Read more